A Science and Technology Blog
A small inhibitor identified by researchers from the University of Hyderabad can block an enzyme (Rad51) that plays a crucial role in repairing DNA damage in malaria-causing Plasmodium falciparum. The inhibitor,…
IIT Mandi team has found that the FDA-approved drug for malaria (hydroxychloroquine or HCQ) binds to the protease enzyme of the Zika virus and stops the virus from replicating and…
For the first time an Indian philanthropic organisation will be funding science to combat infectious diseases. The India Health Fund (IHF), an initiative by Tata Trusts, in collaboration with the…
A team led by researchers from JNU and ICGEB, New Delhi has identified a molecule that prevents malaria parasites from invading red blood cells (RBCs) and causing the disease. It prevents the…
Dr. Manu Prakash is once again at his best — solving complex problems in an extraordinarily simple fashion. Using wingbeat sound, location and time of recording, Dr. Prakash and his…
Effects of using hydroxychloroquine in pregnant women over a long term remains to be assessed. Commonly used malaria drug hydroxychloroquine can effectively block Zika virus from crossing the placenta and…
Beginning next year, the World Health Organisation will begin pilot tests of the injectable malaria vaccine RTS,S (or Mosquirix) on 750,000 children aged 5-17 months in Ghana, Kenya and Malawi.…
On the health front, the year 2016 witnessed a few setbacks and but also a few positive developments. Here are the most important health developments of 2016 1. Trial results…
